Tech — Software
GoodRx Holdings Executive Compensation (FY25)
GDRX · Santa Monica, CA · Executive and director compensation, fiscal 2022 to 2025
Data as of September 7, 2026Latest filing (8-K): June 18, 2026
148 figures on this page: 144 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
Wendy Barnes was paid $23,367,483 in total compensation as Chief Executive Officer & President for fiscal 2025, and the company reported 2 named executive officers for fiscal 2025; the disclosed peer group names 23andMe Holding Co., Accolade, Inc., Affirm Holdings, Inc., Alarm.com Holdings, Inc. and Alignment Healthcare, Inc., among others, while the say-on-pay proposal drew 99.0% of votes cast for or against in favor at the meeting held June 16, 2026 for fiscal 2025. The compensation disclosed runs fiscal 2022 through fiscal 2025.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Scott Wagner → Wendy Barnes
Frequently asked questions
Answers drawn from the data on this page.
Who is GoodRx Holdings' chief executive and what were they paid?
Wendy Barnes was paid $23,367,483 in total compensation as Chief Executive Officer & President for fiscal 2025.
What was GoodRx Holdings' say-on-pay result?
The say-on-pay proposal drew 99.0% of votes cast for or against in favor at the meeting held June 16, 2026 for fiscal 2025.
Which companies are in GoodRx Holdings' peer group?
The disclosed peer group names 23andMe Holding Co., Accolade, Inc., Affirm Holdings, Inc., Alarm.com Holdings, Inc. and Alignment Healthcare, Inc., among others.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Raj Beri Chief Operating Officer | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | ◇ |
Karsten Voermann Chief Financial Officer | ◇ | ◇ | ◇ | — | — | — | ◇ | ◇ |
Romin Nabiey Chief Accounting Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Babak Azad Chief Marketing Officer and SVP, Marketing & Communications | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Trevor Bezdek Co-Chief Executive Officer | ◇ | ◇ | — | — | — | — | ◇ | ◇ |
Douglas Hirsch Co-Chief Executive Officer | ◇ | — | — | — | — | — | ◇ | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Scott Wagner Interim Chief Executive Officer Served on an interim basis | ◇ | ◇ | — | ◇ | — | — | ◇ | ◇ |
Bansi Nagji Former President, Healthcare Departed during or after this year | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | ◇ |
Douglas Hirsch Chief Mission Officer | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Scott Wagner Interim Chief Executive Officer Served on an interim basis | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Karsten Voermann Chief Financial Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Raj Beri Former Chief Operating Officer Departed during or after this year | ◇ | — | — | ◇ | — | — | ◇ | ◇ |
Romin Nabiey Chief Accounting Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Trevor Bezdek Chairman of the Board | ◇ | ◇ | — | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Wendy Barnes Chief Executive Officer & President | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | ◇ |
Christopher McGinnis Chief Financial Officer & Treasurer | ◇ | ◇ | ◇ | ◇ | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2026
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Raj Beri | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
Fiscal 2022, 2023, 2024, 2025 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Romin Nabiey | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | 05/30/2033 | |
| Option | ◇ | — | ◇ | 09/22/2032 | |
| Option | ◇ | — | ◇ | 03/12/2034 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Karsten Voermann | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 03/12/2034 |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Ian T. Clark | ◇ | ◇ | — | — | — | — | ◇ |
Douglas Hirsch | ◇ | ◇ | — | — | — | — | ◇ |
Ronald E. Bruehlman | ◇ | ◇ | — | — | — | — | ◇ |
Agnes Rey-Giraud | ◇ | ◇ | — | — | — | — | ◇ |
Kelly J. Kennedy | ◇ | ◇ | — | — | — | — | ◇ |
Julie Bradley, Wendy Barnes, Scott Wagner, Gregory Mondre, Trevor Bezdek, Christopher Adams and Dipanjan Deb served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Compensation committee chair | ◇ |
| Nominating and governance chair | ◇ |
Equity is delivered as restricted stock units.
Stock ownership guideline: STOCK OWNERSHIP GUIDELINES listed in table of contents on page 21
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- 23andMe Holding Co. ME
- Accolade, Inc. ACCD
- Affirm Holdings, Inc. AFRM
- Alarm.com Holdings, Inc. ALRM
- Alignment Healthcare, Inc. ALHC
- AppFolio, Inc. APPF
- Asana, Inc. ASAN
- Box, Inc. BOX
- CarGurus, Inc. CARG
- Certara, Inc. CERT
- Doximity, Inc. DOCS
- EngageSmart, Inc. ESMT
- EverCommerce, Inc. EVCM
- HealthEquity, Inc. HQY
- Hims Hers Health, Inc. HIMS
- LegalZoom.com, Inc. LZ
- Marqeta, Inc. MQ
- MultiPlan Corp. symbol not shown
- Nextgen Healthcare, Inc. NXGN
- Phreesia, Inc. PHR
- Premier, Inc. PINC
- Privia Health Group, Inc. PRVA
- Progyny, Inc. PGNY
- Q2 Holdings, Inc. QTWO
- Sharecare, Inc. SHCR
- Squarespace, Inc. SQSP
- Teladoc Health, Inc. TDOC
- Vertex, Inc. VERX
- ZipRecruiter, Inc. ZIP
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 16, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 3, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 6, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | June 14, 2023 | = | ◇ | ◇ | ◇ |
What this page does not include
Everything above is a fact GoodRx Holdings disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where GoodRx Holdings sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
148 figures on this page: 144 cited to the filing that reported them, 4 calculated from figures it prints.
144 cited to the filing
4 calculated from the filing
Documents cited
- 0001809519-26-000133Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001809519-26-000091DIRECTOR COMPENSATION · GRANTS OF PLAN-BASED AWARDS · SUMMARY COMPENSATION TABLE
- 0001809519-25-000088Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001809519-25-000063OUTSTANDING EQUITY AWARDS AT YEAR-END · SUMMARY COMPENSATION TABLE
- 0001809519-24-000104Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001809519-24-000062SUMMARY COMPENSATION TABLE
- 0000950170-23-028633Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-23-016311SUMMARY COMPENSATION TABLE
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “GoodRx Holdings executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/GDRX (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about GoodRx Holdings and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Tech — Software rankings
Peers GoodRx Holdings discloses
The companies named in GDRX's own disclosed peer group.
Terms on this page
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}